FARE Clinical Trial Finder

Simplify your search for a clinical trial and help researchers discover new therapies. The FARE Clinical Trial Finder links patients with food allergy and healthy, non-patient volunteers to actively recruiting food allergy studies.

Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies

Study Purpose

Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from:

  • - People signed up by the investigators at the University of Colorado Denver - University of North Carolina and Massachusetts General Hospital where people have been treated for peanut allergies - University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges.
Blood and health histories from the University of North Carolina, Massachusetts General Hospital, National Jewish Health, and The Children's Hospital will not have personal information linked. The specific aims of this experiment are: 1. Come up with a lab test that will predict how bad an allergic reaction will be to peanuts. 2. Find out what part of a peanut causes allergic reactions. 3. Come up with preventions that can block peanut allergies. 4. Find the strongest proteins in walnuts.

Recruitment Criteria

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Accepts Healthy Volunteers
Yes

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Study Type
Observational
Eligible Ages 1 Year - 75 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

This protocol is to draw blood for a variety of related studies of food allergy. For this reason, we will list each group of subjects and the inclusion criteria for that group. 1. De-identified sera or plasma from patients who have undergone Oral ImmunoTherapy (OIT) for peanut allergy. These samples already exist.
  • -

    Inclusion criteria:

    1.
patients have been enrolled in a controlled trial of OIT for peanuts, and had at least one oral challenge. 2. Age 1-75. 2. De-identified samples from patients who are undergoing clinically indicated food challenges for peanut allergy.
  • -

    Inclusion criteria:

    1.
concern regarding possible allergy to peanuts, 2. age 1-75, 3. plan to undergo a clinically indicated challenge with peanuts. 3. Patients with peanut allergy.
  • -

    Inclusion criteria:

    1.
excellent history of a systemic reaction to peanuts, 2. age 6-75. 4. Patients with other food allergies (especially tree nuts).
  • -

    Inclusion criteria:

    1.
excellent history of a systemic reaction to tree nuts or other foods, 2. age 6-75. 5. Normal controls.
  • -

    Inclusion criteria:

    1.
no known food allergies, 2. recent ingestion of peanuts without difficulty, and 3. age 6-75.

Exclusion Criteria:

1. Any known significant medical or psychiatric diagnosis 2. Use of an investigational drug within 30 days 3. Use of omalizumab (anti-IgE; Xolair) within 6 months

Trial Details

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

Trial ID:
NCT02192866

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Lead Sponsor
University of Colorado, Denver

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator
Stephen Dreskin, MD, PhD
Principal Investigator Affiliation University of Colorado, Denver

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Agency Class
OtherNIH
Overall Status Recruiting
Countries United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Conditions
Peanut Allergies, Tree Nut Allergies, Other Food Allergies

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

University of Colorado, Aurora, Colorado

Status

Recruiting

Address

University of Colorado

Aurora, Colorado, 80045

Site Contact

Spodra Eglite

Spodra.Eglite@ucdenver.edu

303-724-7193

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.